- Joined
- Apr 3, 2019
- Messages
- 4,752
- Reaction score
- 11,006
Most insurance companies don’t allow SRS for SCLC brain mets and so instead push WBRTOut of curiosity - which regimens are being pushed that you feel have less efficacy?
Most insurance companies allow up to 21 fractions of RT for very low risk breast cancer and thus push increased toxicity and out of pocket costs where 5 fractions would be sufficient
Most insurance companies allow up to 35 fractions for stage III NSCLC pushing perhaps increased toxicity by doing so
Most insurance companies say protons and IMRT are equal for prostate cancer thus pushing the proton palaces to deliver more protons for prostate than they would otherwise
I could go on!